The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 18, 2021

Filed:

Jan. 27, 2017
Applicant:

National University Corporation Hokkaido University, Sapporo, JP;

Inventor:

Shin-Ichiro Nishimura, Sapporo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 9/14 (2006.01); A61K 31/44 (2006.01); A61K 47/24 (2006.01); A61K 47/34 (2017.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 47/6925 (2017.08); A61K 9/14 (2013.01); A61K 31/44 (2013.01); A61K 47/24 (2013.01); A61K 47/34 (2013.01); A61K 47/6923 (2017.08); B82Y 5/00 (2013.01);
Abstract

The present invention pertains to a complex including nanoparticles and, carried on the surface of the nanoparticles, a lysosomal enzyme inhibitor or kinase inhibitor shown by general formula (A) and a phospholipid mimetic substance shown by general formula (B). In general formula (A), n1 is an integer of 2-30, n2 is an integer of 2-30, the -S- terminal is a nanoparticle-carrying site, and R10 is a suicide substrate site or a kinase inhibition site. In general formula (B), n3 is an integer in the range of 2-30, and the -S- terminal is a nanoparticle-carrying site. The present invention provides a versatile system capable of efficiently delivering a drug to endolysosomes and allowing the drug to function at a low concentration on lysosomal enzymes, and an anticancer agent in which this system is used.


Find Patent Forward Citations

Loading…